Resources

ASP Policies

FDA Drug Shortages (Updated Bi-monthly)

UCLA Formulary Antimicrobials Status (As of 12.7.2023) Management

Amoxicillin oral powder for suspension

 First posted: 10/29/22 On allocation

Consider switching to another formulation or amoxicillin clavulanate

Amphotericin B Deoxycholate (conventional)

 First posted: 8/5/2022 Backordered

Supply is anticipated to return 2024. Please switch to an alternative amphotericin formulation or another antifungal agent.

Amoxicillin/Clavulanate

 First posted: 2/15/23 On allocation

Consider switching to another formulation

Cefdinir

 First posted: 06/29/2023 On allocation

Suspension formulations and 300 mg capsules are on allocation; May need to switch to different capsule size or different cephalosporin

Cefixime

First posted: 1/21/2022 On Backorder

Consider switching to another oral cephalosporine
Ciprofloxacin Injectable

First posted: 01/08/2024

Limited supply

 May need to switch to oral ciprofloxacin or intravenous levofloxacin
Clindamycin Vials First posted: 09/07/2022
Limited supply		 Encourage switch to oral formulation or alternative agent
Dicloxacillin Sodium Capsules First posted: 07/20/2022
Backordered		 Encourage switch to another antistaphylococcal agent (i.e. amoxicillin-clavulanate, cephalexin, cefadroxil)
Gentamicin Sulfate Injectable First posted: 07/03/2021
Backordered

Encourage switch to aminoglycoside or alternative agent

Isoniazid Tablet

 First posted: 9/1/2022 Available but on allocation

300 mg are on allocation. Patient may need to take 100 mg tablets
Levofloxacin oral solution First posted: 9/15/23 Backordered May need to switch to tablet formulation
Metronidazole Injectable First posted: 01/03/2022
Available but on allocation

Encourage switch to oral formulation
Nirsevimab Intramuscular Injection (Beyfortus) First posted: 10/23/23 Limited availability The CDC has provided interim recommendations during this shortage to prioritize patients with the highest risk for severe RSV disease. Avoid using two 50 mg doses for infants weighing more than 5 kg (>11 lbs). For palivizumab-eligible children aged 8-10 months, use palivizumab for the 2023-2024 RSV season unless the patient is an American Indian/Alaskan native aged 8-10 months who is not eligible for palivizumab. This full guidance can be found at: https://emergency.cdc.gov/han/2023/han00499.asp 

Oseltamivir Suspension and Capsules

First posted 11/1/2022 Available but may be on allocation

May need to switch to a different capsule size or a different antiviral medication

Penicillin G Benzathine or Procaine

 First posted: 02.01.23 Limited supply

Continue to follow CDC’s Treatment recommendations. Penicillin G benzathine (Bicillin L-A®) is the only recommended treatment for pregnant people infected or exposed to syphilis. Doxycycline 100mg PO BID for two weeks (for early syphilis) or for 4 weeks (for late latent or syphilis of unknown duration) is an alternative for the treatment of non-pregnant people with a penicillin allergy. Please prioritize the use of Bicillin L-A® to treat pregnant people and babies with congenital syphilis

Valganciclovir Tablets and Oral Solution

 First posted; 02/08/23 Backordered until mid April 

Prefer use of oral solution for IP, try to reserve tablet formulation for OP

Duration of Antibiotic Therapy

Data suggests that shorter courses are equivalent to longer courses with respect to achieving clinical cure and result in much fewer adverse events. Below is a review of the existing data on antibiotic durations for different infectious disease syndromes.

Presentations